Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas
Status:
Withdrawn
Trial end date:
2018-04-18
Target enrollment:
Participant gender:
Summary
Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent non-Hodgkin
Lymphomas Patients Using Daclatasvir and Asunaprevir: A Pilot Study